
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for C2PU.SI and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for C2PU.SI and 80,000+ other tickers.
See exactly how C2PU.SI's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for C2PU.SI and 80,000+ other tickers.
Parkway Life Real Estate Investment Trust (PLife REIT) is recognized as one of Asia's foremost publicly listed healthcare REITs based on its significant asset holdings. The trust's investment strategy focuses on acquiring income-generating real estate and associated assets predominantly utilized for healthcare and related services. This comprehensive mandate covers hospitals, various medical facilities, and properties supporting healthcare research, education, and the production or warehousing of pharmaceuticals, medical goods, and devices. As of December 31, 2020, PLife REIT managed a robust…
No recent news available.